cGxP.wire https://validator.w3.org/feed/docs/rss2.html Solu Therapeutics Wins FDA Fast Track for STX-0712 TOBY Gains FDA Breakthrough Status for Alzheimer’s Test Gene Solutions Wins FDA Breakthrough Status for SPOT-MAS 10 Abbott Strengthens Leadership in CRC Screening AbbVie Wins FDA Approval for DECNUPAZ in Rare Blood Cancer Vanda Gains Japan Orphan Status for Imsidolimab Brii Bio Reports Positive ENSURE HBV Cure Study Results Nanoscope Therapeutics Partners With McKesson for Retinal Therapy Ono Pharma Highlights New Phase 2 MSA Data Nuvalent Expands Leadership in Precision Lung Cancer Dizal Advances ZEGFROVY for EGFR Lung Cancer Apogee Therapeutics Lands $1.3B Blackstone Deal Foresee Pharmaceuticals Reports Positive CPP Phase 3 Data ARTHEx Biotech Advances ATX-01 for Myotonic Dystrophy Zealand Pharma Showcases Petrelintide Obesity Data Hansa Biopharma Reports Positive Idefirix Results Gilead Reports Strong Long-Term Livdelzi PBC Data Precision BioSciences Reveals Breakthrough HBV Data Brenus Pharma Wins FDA IND Clearance for STC-1010 TransCode Starts Phase 2a Trial for TTX-MC138 Senzime Secures FDA Clearance for Enhanced TetraGraph Yuka Report Highlights Ultra-Processed Food Crisis Consano Bio Starts Phase 1 Trial for C-1101 Therapy Mercy BioAnalytics Advances Blood-Based Lung Cancer Screening Ginkgo Bioworks, Inductive Bio and Tangible Launch ADME-One Jade Biosciences Doses First Patient With JADE201 Myriad Launches Prolaris + AI for Prostate Cancer Soligenix Advances Bundibugyo Ebola Vaccine Platform Apogee to Reveal Phase 2 Zumilokibart AD Data Virax Biolabs Reports Positive Long COVID Data Citius Oncology LYMPHIR ASCO Phase 1 Data Emalex Ecopipam Phase 3 Tourette Data Published Cosmos Health Targets $200M Revenue Growth by 2029 Marea MAR002 Acromegaly Data Set for ENDO 2026 Merz and Kvvit Partner to Expand INBRIJA Access Lilly Acquires Curevo, LimmaTech and Vaccine Company MediciNova Completes Phase 2 MN-001 Trial in NAFLD WuXi Vaccines Receives ANVISA GMP Approval for Dengue Vaccine FibroBiologics Reports Durable Psoriasis Immunomodulation Data at SID 2026 Adcendo and MSD Expand KEYTRUDA Cancer Trial Oncolytics’ Pelareorep Shows Strong KRAS-Targeted Immune Activation at ASCO 2026 AGC Biologics to Manufacture Teikoku’s rhMMP-7 ClearNote Health to Present Strong ASCO 2026 Data for Avantect Pancreatic Cancer Blood Test Abivax Reports Strong Three-Year Remission Results for Obefazimod in Ulcerative Colitis Subtle Medical Gains FDA Clearance for SubtleHD PET Olympus to Acquire BioProtect for Prostate Cancer Care TreeFrog’s TFG-001 Shows Strong Parkinson’s Recovery Data Agios Secures EU Approval for PYRUKYND in Thalassemia Henlius Advances HLX316 Into First Human Cancer Trial Ironwood Wins FDA Approval for Pediatric LINZESS